Clinical study of temafloxacin in urinary tract infections
スポンサーリンク
概要
- 論文の詳細を見る
We performed a clinical evaluation of temafloxacin (TMFX) in urinary tract infections (UTI). TMFX was administered to 5 patients with uncomplicated urinary tract infections ata daily dose of 300 mg for 3-7 days, and to 19 patients with complicated urinary tract infections at a daily dose of 300 or 600 mg for 5 days.<BR>According to the criteria of the Japanese UTI Committee (3rd. Ed), the efficacy rate was 100% in uncomplicated urinary tract infections and 80% in complicated urinary tract infections.<BR>No serious side effects were observed. Laboratory abnormalities consisted of elevation of GOT and GPT in one case, elevation of GOT, GPT, ALP, LDH and γ-GTP in one case, and elevation of GOT, GPT, ALP and y-GTP in one case.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.